Search - tctmd.com

Displaying 201 - 220 of 2970

Sort: Relevancy | Date

News Conference News CRT 2023

Small Study Highlights the Serious Nature of Coronary Stent Infections

Yael L. Maxwell

March 04, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Daily News

SCAI Updates Position on Doing PCI Without Surgical Backup

Michael O'Riordan

February 20, 2023

News Daily News

Intravascular Imaging to Inform PCI Should Be Routine: ACC Interventional Council

Yael L. Maxwell

February 13, 2023

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Yael L. Maxwell

February 06, 2023

News Conference News STS 2023

Large Medicare Analysis Reopens Debate Over Multivessel Revascularization

Yael L. Maxwell

January 24, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Conference News ISET 2023

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Caitlin E. Cox

January 20, 2023

News Daily News

Brachytherapy Remains an Option for DES In-Stent Restenosis

Yael L. Maxwell

January 12, 2023

News Daily News

Routine Coronary Tests Prior to Kidney Transplant Questioned

Yael L. Maxwell

January 05, 2023

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News AHA 2022

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

Yael L. Maxwell

November 10, 2022

News Features

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

L.A. McKeown

October 18, 2022

News Conference News TCT 2022

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Yael L. Maxwell

September 27, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

News Conference News TCT 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

L.A. McKeown

September 20, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

Presenter: Pablo Salinas

September 19, 2022

Presentation TCT 2022

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Presenter: Jonas Haener

September 19, 2022

Advertisement

Small Study Highlights the Serious Nature of Coronary Stent Infections

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

SCAI Updates Position on Doing PCI Without Surgical Backup

Intravascular Imaging to Inform PCI Should Be Routine: ACC Interventional Council

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Large Medicare Analysis Reopens Debate Over Multivessel Revascularization

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Brachytherapy Remains an Option for DES In-Stent Restenosis

Routine Coronary Tests Prior to Kidney Transplant Questioned

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content